Sippican Capital Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-9,289
Closed -$698K 115
2025
Q3
$698K Sell
9,289
-799
-8% -$59.6K 0.46% 71
2025
Q2
$747K Sell
10,088
-6,259
-38% -$436K 0.54% 65
2025
Q1
$1.32M Hold
16,347
0.99% 41
2024
Q4
$1.28M Sell
16,347
-249
-2% -$21.2K 0.93% 40
2024
Q3
$1.56M Hold
16,596
1.09% 33
2024
Q2
$1.29M Sell
16,596
-295
-2% -$24.1K 1.02% 36
2024
Q1
$1.54M Hold
16,891
1.19% 32
2023
Q4
$1.31M Buy
16,891
+552
+3% +$38.7K 1.02% 39
2023
Q3
$1.11M Buy
16,339
+5,896
+56% +$429K 1% 39
2023
Q2
$848K Buy
10,443
+2,387
+30% +$190K 0.78% 53
2023
Q1
$661K Buy
+8,056
New +$575K 0.63% 63

Other funds holding GEHC

Sippican Capital Advisors's GEHC Position: Q4 2025 in Review

Sippican Capital Advisors sold out of GE HealthCare (GEHC) in Q4 2025, closing a stake of 9,289 shares — an estimated $698K sold.

Sippican Capital Advisors first reported a position in GEHC in Q1 2023 and held it in 11 quarters. The position peaked at $1.56M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold GEHC as of Q4 2025.

  • Sippican Capital Advisors reported no remaining GE HealthCare position as of Q4 2025 after selling out during the quarter.
  • Sippican Capital Advisors sold 9,289 GE HealthCare shares in Q4 2025, an estimated $698K.
  • Sippican Capital Advisors first reported a position in GE HealthCare in Q1 2023 and held it in 11 quarters.
  • Sippican Capital Advisors's GE HealthCare position peaked at $1.56M in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2025.

Based on Sippican Capital Advisors's 13F filing for Q4 2025, filed 23 Jan 2026.